1. Home
  2. TENX vs JRSH Comparison

TENX vs JRSH Comparison

Compare TENX & JRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

N/A

Current Price

$1.72

Market Cap

74.1M

Sector

Health Care

ML Signal

N/A

Logo Jerash Holdings (US) Inc.

JRSH

Jerash Holdings (US) Inc.

N/A

Current Price

$5.97

Market Cap

68.8M

ML Signal

N/A

Company Overview

Basic Information
Metric
TENX
JRSH
Founded
1967
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
74.1M
68.8M
IPO Year
2001
2017

Fundamental Metrics

Financial Performance
Metric
TENX
JRSH
Price
$1.72
$5.97
Analyst Decision
Buy
Strong Buy
Analyst Count
10
2
Target Price
★ $9.63
$6.50
AVG Volume (30 Days)
★ 2.0M
93.7K
Earning Date
11-11-2026
11-11-2026
Dividend Yield
N/A
★ 3.36%
EPS Growth
N/A
★ 485.71
EPS
N/A
★ 0.13
Revenue
N/A
★ $166,263,870.00
Revenue This Year
N/A
$14.07
Revenue Next Year
N/A
$7.46
P/E Ratio
★ N/A
$45.96
Revenue Growth
N/A
★ 14.03
52 Week Low
$1.31
$2.85
52 Week High
$19.40
$6.67

Technical Indicators

Market Signals
Indicator
TENX
JRSH
Relative Strength Index (RSI) 42.67 49.87
Support Level $1.34 $3.11
Resistance Level $2.00 $6.67
Average True Range (ATR) 0.12 0.23
MACD 0.09 -0.05
Stochastic Oscillator 70.91 15.84

Price Performance

Historical Comparison
TENX
JRSH

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

Share on Social Networks: